Exploring the role of Nrf2 signaling in glioblastoma multiforme

Glioblastoma multiforme (GBM) is one of the most aggressive glial cell tumors in adults. Although current treatment options for GBM offer some therapeutic benefit, median survival remains poor and does not generally exceed 14 months. Several genes, such as isocitrate dehydrogenase (IDH) enzyme and O...

Descripción completa

Detalles Bibliográficos
Autores principales: Awuah, Wireko Andrew, Toufik, Abdul-Rahman, Yarlagadda, Rohan, Mikhailova, Tatiana, Mehta, Aashna, Huang, Helen, Kundu, Mrinmoy, Lopes, Leilani, Benson, Sylvester, Mykola, Lyndin, Vladyslav, Sikora, Alexiou, Athanasios, Alghamdi, Badrah S., Hashem, Anwar M., Md Ashraf, Ghulam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519816/
https://www.ncbi.nlm.nih.gov/pubmed/36169772
http://dx.doi.org/10.1007/s12672-022-00556-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519816/
https://www.ncbi.nlm.nih.gov/pubmed/36169772
http://dx.doi.org/10.1007/s12672-022-00556-4

Ejemplares similares